Overview of lymphocyte development
 
Lymphocytes develop from a common lymphoid progenitor cell. B cells mature primarily in the bone marrow, whereas T cells mature in the thymus. Although the process and signals of maturation differ between the 2 cell types, they rely on similar genetic events to generate specific antibodies or cell surface receptors. These gene rearrangements are critical for the development of a broad immune repertoire and also provide molecular markers of clonality that can be used to diagnose lymphoid malignancies.

B-cell development
B-cell maturation consists of early (antigen-independent) and late (antigen-dependent) stages. Early development is initiated by the rearrangement of genes for the heavy . . . [Full Text of this Article]

T-cell development
Biology of lymphomas
Diagnostic testing in lymphoproliferative disorders
Morphology
Immunophenotyping
Molecular genetics/cytogenetics
Classification of lymphomas

Non-Hodgkin lymphomas
 
Classification
Epidemiology, pathogenesis, and molecular characterization
Gene signatures in lymphoma
Staging and prognostic factors
Patient follow-up
Indolent B-cell NHL
Follicular lymphoma
Management of patients with localized follicular lymphoma
Primary therapy of advanced-stage follicular lymphoma
Therapy for relapsed and refractory follicular lymphoma
High-dose chemotherapy and ASCT
Tumor vaccine approaches
Marginal zone lymphomas
MALT lymphomas
Nodal MZL
Splenic MZL
Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia
Hairy cell leukemia
Transformation to aggressive lymphoma in indolent lymphomas
Aggressive B-cell lymphomas
Diffuse large B-cell lymphoma
Treatment of advanced-stage DLBCL
Treatment of localized DLBCL
Assessment of therapeutic response in DLBCL
Relapsed and refractory DLBCL
Primary mediastinal (thymic) large B-cell lymphoma
Burkitt lymphoma
Mantle cell lymphoma
Peripheral T-cell lymphomas
Indolent PTCLs
Aggressive PTCLs
PTCL–not otherwise specified
Angioimmunoblastic T-cell lymphoma
Anaplastic large-cell lymphoma
Extranodal NK/T-cell lymphoma, nasal-type
Rare PTCL subtypes
Primary cutaneous PTCL, rare aggressive subtypes

Immunodeficiency-associated lymphoproliferative disorders
 
Primary CNS lymphoma
NHLs in children

Hodgkin lymphoma
 
Pathology
Classical Hodgkin lymphoma
Nodular sclerosis CHL
Mixed cellularity CHL
Lymphocyte-rich CHL
Lymphocyte-depleted CHL
Nodular lymphocyte-predominant HL
Staging and prognostic factors
Treatment of HL
Treatment of early-stage HL
Treatment of advanced-stage HL
Treatment of relapsed/refractory disease
Hematopoietic stem cell transplantation
HL in children
Long-term complications of HL therapy